Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
Zhang, Wei-Wei, Bai, Feng, Wang, Jing, Zheng, Rong-Hua, Yang, Li-Wang, James, Erskine, Zhao, Zhi-QingVolume:
Volume 11
Language:
english
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S144807
Date:
October, 2017
File:
PDF, 1.82 MB
english, 2017